Timothy Flanigan is an Infectious Disease physician. OpenAlex indexes 382 publications with 16,587 citations (h-index 64); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
164 Summit Ave
Fain Bldg., Suite E
Providence, RI 029062853
Telephone
401-793-2928Registry record last updated 14 Nov 2007.
Clinical trials
- Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20231 payment
- Abbott LaboratoriesProgram year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
45.2%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor20.1%Dovato64%Tivicay26%Juluca10%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor7.1%Descovy53%Triumeq47%Part D<11 patients+ 8 more classes in this area
Nervous system
25.5%Benzodiazepine6.3%Lorazepam61%Clonazepam39%Part D<11 patientsOpioid Agonist4.6%Morphine Sulfate Er73%Oxycodone-Acetaminophen27%Part D<11 patients+ 6 more classes in this area
Cardiovascular
12.5%Statin6.1%Atorvastatin Calcium75%Pravastatin Sodium25%Part D<11 patientsCalcium channel blocker2.3%Amlodipine Besylate100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
14 NIH research awards on record, funded 1991–2026 per NIH RePORTER. The latest:
- Building Capacity in HIV/TB and Mental Health in Ukraine's Humanitarian Crisis
Brown University
FY2026$282,949D43TW012768 - Building Capacity in HIV/TB and Mental Health in Ukraine's Humanitarian Crisis
Brown University
FY2026$19,440D43TW012768 - Building Capacity in HIV/TB and Mental Health in Ukraine's Humanitarian Crisis
Brown University
FY2025$305,792D43TW012768
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
New England Journal of Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”